Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chisa Murazawa"'
Autor:
Chisa Murazawa, Nozomi Hashimoto, Kana Kuraishi, Mutsumi Motoyama, Shin-Ichiro Hashimoto, Mayumi Ikeuchi, Shoko Norimura, Toru Matsunaga, Koji Teramoto, Reiji Haba, Noriko Abe, Toshiki Yajima, Keiichi Kontani
Publikováno v:
Oncology Letters. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e85ac5c8ab435fb737ea68fd624f7f3
https://doi.org/10.3892/ol.2023.13750
https://doi.org/10.3892/ol.2023.13750
Autor:
Chisa, Murazawa, Keiichi, Kontani, Shinichiro, Hashimoto, Nozomi, Hashimoto, Shoko, Norimura, Masahiro, Ohtani, Manabu, Date, Hiroyasu, Yokomise
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(9)
We report 4 female patients with metastatic breast cancer who were administered TS-1 as a late-line treatment and showed favorable outcomes. Their average age was 66.3. The patients, all of whom had undergone prior treatment with both anthracyclines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dc89c7643d0b867f9dc1f59100dc0d14
https://pubmed.ncbi.nlm.nih.gov/31530791
https://pubmed.ncbi.nlm.nih.gov/31530791
Autor:
Shoko, Norimura, Keiichi, Kontani, Atsushi, Morishita, Takako, Kubo, Chisa, Murazawa, Shinichiro, Hashimoto, Nozomi, Hashimoto, Koichiro, Kenzaki, Kazumasa, Miura, Hiroyasu, Yokomise
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(12)
Febrile neutropenia(FN)is a frequent adverse event observed in cancer patients undergoing chemotherapy that may cause life-threatening infections. However, reducing the dose of anti-cancer drugs for breast cancer in adjuvant settings to prevent FN ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f61e8a4e50b5a5cdbe2912b7045227fc
https://pubmed.ncbi.nlm.nih.gov/30587729
https://pubmed.ncbi.nlm.nih.gov/30587729
Autor:
Naomi Fujiwara-Honjo, Manabu Date, Shoko Norimura, Hitoshi Houchi, Shinichiro Hashimoto, Masahiro Ohtani, Hiroyasu Yokomise, Keiichi Kontani, Hiroaki Tanaka, Koji Teramoto, Chisa Murazawa
Publikováno v:
Molecular and Clinical Oncology. 4:947-953
The survival of patients with metastatic breast cancer (MBC) has not improved, despite recent advances in therapeutic strategies. This is mainly due to the fact that cytotoxic agents cannot be administered over a long period, even if they exhibit fav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b22575c3f7de48a8d81d22c19b6291
https://doi.org/10.3892/mco.2016.841
https://doi.org/10.3892/mco.2016.841
Autor:
Naomi Fujiwara-Honjo, Reiji Haba, Chisa Murazawa, Masahiro Ohtani, Keiichi Kontani, Hiroaki Tanaka, Yoshio Kushida, Manabu Date, Hitoshi Houchi, Shinichiro Hashimoto, Akira Yamauchi, Noriyuki Kuroda, Shoko Norimura, Hiroyasu Yokomise
Publikováno v:
Cancer Biology & Therapy. 14:20-28
We assessed the clinical usefulness of human epidermal growth factor receptor-2 extracellular domain (HER2ECD) as a biomarker for detecting cancer and monitoring disease status and for predicting the efficacy of anticancer treatment in breast cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9ac916e76debfe4d6091cc5abe77e9
https://doi.org/10.4161/cbt.22626
https://doi.org/10.4161/cbt.22626
Autor:
Masahiro Ohtani, Chisa Murazawa, Keiichi Kontani, Shoko Norimura, Hiroaki Tanaka, Hitoshi Houchi, Manabu Date, Shinichiro Hashimoto, Naomi Fujiwara-Honjo, Hiroyasu Yokomise
Publikováno v:
Molecular and Clinical Oncology. 1:225-230
The objective of treatment for metastatic breast cancer (MBC) is to control the disease or disease-related symptoms. Prolonged survival has also often been achieved by chemotherapeutic regimens in this setting. Long-term administration of one therape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554ca137675c9874f19fdeef3112f531
https://doi.org/10.3892/mco.2012.49
https://doi.org/10.3892/mco.2012.49
Autor:
Akira Tangoku, Kazumasa Miura, Chisa Murazawa, Shoko Norimura, Kiyoshi Yoshizawa, Dage Liu, Shinichiro Hashimoto, Hiroyasu Yokomise, Takako Kubo, Masafumi Tamaki, Fuminori Aki, Koichiro Kenzaki, Keiichi Kontani
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 14, Iss 2, Pp 409-415 (2018)
Background: Since breast cancer shows diversity in clinical behaviors, a standard therapy does not always lead to favorable outcomes. Materials and Methods: The expression statuses of candidate markers, including topoisomerase-II alpha (TOP2A), beta-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7bf9882d590daed810841929120c11
https://doi.org/10.4103/jcrt.jcrt_1053_16
https://doi.org/10.4103/jcrt.jcrt_1053_16
Autor:
Akira Yamauchi, Toshihiko Ishida, Shin Ichi Hayashi, Chisa Murazawa, Xueyuan Cao, Norio Kohno, Hitomi Imachi, Hiroo Nakajima, Hirotaka Iwase, Hiroko Yamashita, Mohammad M. Bhuyan, Keiichi Kontani, Hiroaki Dobashi, Shoko Niki, Koji Murao
Publikováno v:
Breast Cancer Research and Treatment. 122:395-407
Multiple coactivator and corepressor complexes play an important role in endocrine processes and breast cancer; in particular, estrogen and estrogen receptor-alpha (ERalpha) promote the proliferation of breast cancer cells. Menin is a tumor suppresso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a3ccfdf66ffcf22b6f9972205307f0
https://doi.org/10.1007/s10549-009-0581-0
https://doi.org/10.1007/s10549-009-0581-0
Autor:
Hiroyasu Yokomise, Hiroaki Tanaka, Koji Teramoto, Hitoshi Houchi, Shinichiro Hashimoto, Shoko Norimura, Chisa Murazawa, Masahiro Ohtani, Naomi Fujiwara-Honjo, Manabu Date, Keiichi Kontani
Publikováno v:
World Journal of Surgical Oncology
Background Although survival of patients with metastatic breast cancer (MBC) has been significantly prolonged over the past decade due to improvement of anti-cancer therapeutics, only a few patients survive for more than 10 years. It has not been det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b3831fa525ccf505255470f0ec87d27
http://europepmc.org/articles/PMC4236407
http://europepmc.org/articles/PMC4236407
Indication for skin-sparing mastectomy with or without nipple preservation for primary breast cancer
Autor:
Keiichi, Kontani, Chisa, Murazawa, Shoko, Norimura, Kanako, Yamashita, Naomi, Fujiwara-Honjo, Masahiro, Ohtani, Manabu, Date, Yoshio, Kushida, Gan, Muneuchi, Reiji, Haba, Hiroyasu, Yokomise, Akira, Yamauchi
Publikováno v:
International surgery. 95(1)
Skin-sparing mastectomy (SSM) is one of the available operation methods for breast cancer. We discuss here indications for SSM for primary breast cancer. We carried out SSM for 28 patients with breast cancer. Their clinical features were compared wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53bc2ef023aafa618ceea5ecf83c957f
https://pubmed.ncbi.nlm.nih.gov/20480835
https://pubmed.ncbi.nlm.nih.gov/20480835